Home > Latest News on ID > Interesting Papers

ALLStaphylococcus aureusStreptococcus pneumoniaeEnterococcusEnterobacteriaceaePseudomonas,AcinetobacterOther bacterial infectionOther bacterial infectionClinical issues on bacterial infectionsVaccines LOGIN No. Category Subject Date Read 129 Staphylococcus aureus Geographic distribution of S. aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med. 2010;7(1):e1000215 2010-03-03 4431 128 Clinical issues on bacterial infections Antibiotics for community-acquired pneumonia. J Antimicrob Chemother. 2009;64(6):1123-5. 2010-02-16 4454 127 Clinical issues on bacterial infections CAP due to pandemic A(H1N1)2009 influenza virus and MRSA co-infection. PLoS One. 2010;5(1):e8705 2010-02-16 4428 126 Clinical issues on bacterial infections Overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine. 2009;27(52):7282-91 2010-02-03 4864 125 Vaccines Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA. Expert Rev Anti Infect Ther. 2010;8(2):117-25 2010-02-03 4789 124 Pseudomonas, Acinetobacter Worldwide dissemination of the blaOXA-23 carbapenemase gene of A. baumannii. Emerg Infect Dis. 2010 Jan;16(1):35-40 2010-02-03 4650 123 Pseudomonas, Acinetobacter Global spread of carbapenem-resistant A. baumannii. J Antimicrob Chemother. 2010;65(2):233-8 2010-02-03 4804 122 Staphylococcus aureus CA-MRSA in outpatients, United States, 1999-2006. Emerg Infect Dis. 2009 Dec;15(12):1925-30 2010-01-06 4921 121 Staphylococcus aureus CA-MRSA as a cause of hospital-acquired infections. J Hosp Infect. 2009;73(4):364-70 2010-01-06 4830 120 Clinical issues on bacterial infections Swine flu and antibiotics. J Antimicrob Chemother. 2009;64(5):889-94 2010-01-06 4892 119 Pseudomonas, Acinetobacter MDR P. aeruginosa and A. baumannii: resistance mechanisms and implications for therapy. Expert Rev Anti Infect Ther. 2010;8(1):71-93 2009-12-31 5006 118 Pseudomonas, Acinetobacter Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant A. baumannii around London. IJAA.2010;35:19-24 2009-12-31 4852 117 Pseudomonas, Acinetobacter Imipenem resistance in P. aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes Infect Control Hosp Epidemiol. 2010 2009-12-16 5176 116 Pseudomonas, Acinetobacter Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific Respirology. 2009 Nov; 2009-12-16 5253 115 Pseudomonas, Acinetobacter Epidemiology and impact of imipenem resistance in Acinetobacter baumannii Infect Control Hosp Epidemiol. 2009 Dec;30(12):1186-92 2009-12-16 5172 Page: 1 . 2 . 3 . 4 . 5 . 6 . 7 . 8 . 9 . 10 . ... 11

134534839031   Writer Subject Content